Fellowship · Kansas City, KS
Sponsored by University of Kansas School of Medicine
2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Arthritis & rheumatology (Hoboken, N.J.) · 2021 · 510 citations · Mehrdad Maz
2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Giant Cell Arteritis and Takayasu Arteritis.
Arthritis & rheumatology (Hoboken, N.J.) · 2021 · 457 citations · Mehrdad Maz
2025 American College of Rheumatology (ACR) Guideline for the Treatment of Systemic Lupus Erythematosus.
Arthritis care & research · 2026 · 48 citations · Kimberly Liang
2025 American College of Rheumatology (ACR) Guideline for the Treatment of Systemic Lupus Erythematosus.
Arthritis & rheumatology (Hoboken, N.J.) · 2026 · 22 citations · Kimberly Liang
CD40 ligand antagonist dazodalibep in Sjögren's disease: a randomized, double-blinded, placebo-controlled, phase 2 trial.
Nature medicine · 2024 · 75 citations · Ghaith Noaiseh
2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Arthritis care & research · 2021 · 154 citations ·
Safety and efficacy of subcutaneous iscalimab (CFZ533) in two distinct populations of patients with Sjögren's disease (TWINSS): week 24 results of a randomised, double-blind, placebo-controlled, phase 2b dose-ranging study.
Lancet (London, England) · 2024 · 57 citations · Ghaith Noaiseh
2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Giant Cell Arteritis and Takayasu Arteritis.
Arthritis care & research · 2021 · 103 citations · Mehrdad Maz